COMPARISON OF PLASMA COAGULABILITY AFTER SHORT-TERM TREATMENT WITH ROSUVASTATIN VERSUS ATORVASTATIN IN UNSTABLE ANGINA PATIENTS
Open Access
- 14 September 2020
- journal article
- Published by RS Global Sp. z O.O. in World Science
Abstract
Statins are the integral medications for the management of patients with acute coronary syndrome including unstable angina (UA) with multiple pleiotropic effects. However, the influence of statins on the coagulation system is controversial. Our study aimed to explore the effects of atorvastatin and rosuvastatin in high doses on some coagulation parameters (prothrombin pool (PP) and soluble fibrin-monomer complexes (SFMC) concentration) after a 7-days follow-up period in patients with UA. We recruited 50 patients aged 55 to 70 years with progressive UA. Standard therapy according to ESC guidelines 2020 was recommended for all patients. Before treatment onset, they were divided into 2 groups: group A – 26 patients were prescribed atorvastatin, group R – 24 patients with rosuvastatin treatment. The blood samples to analyze the concentration of PP and SFMC were collected twice – before the treatment onset and 7 days after. We revealed significant decrease in PP concentration (p=0,02) and increase in SFMC concentration (p=0,01) in group A patients while there were no significant changes of investigated parameters (p=0,94, p=0,57 respectively) in group R. Additionally, we have noted significant negative correlation between baseline PP concentration and direction of PP changes (r=-0,803, pKeywords
This publication has 23 references indexed in Scilit:
- Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysisEuropean Journal of Preventive Cardiology, 2015
- Anticoagulant effects of statins and their clinical implicationsThrombosis and Haemostasis, 2014
- The effects of statins on the mevalonic acid pathway in recombinant yeast strains expressing human HMG-CoA reductaseBMC Biotechnology, 2013
- Mechanisms of fibrin polymerization and clinical implicationsBlood, 2013
- Management of Cardiovascular Risk: The Importance of Meeting Lipid TargetsThe American Journal of Cardiology, 2012
- Clopidogrel–Drug InteractionsJournal of Invasive Cardiology, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary interventionAmerican Heart Journal, 2006
- Statins and Blood CoagulationArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromesBlood Coagulation & Fibrinolysis, 2002